Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolong ejaculation.
Popular Articles

California Gov. Schwarzenegger's State Budget Plan Includes Cuts To County HIV/AIDS Services
The Santa Maria Times examines how California Gov. Arnold Schwarzenegger"s (R) plan to reduce state spending by more than $5 billion over the next two fiscal years, which includes millions of dollars in funding cuts to HIV prevention, education and treatment programs, could affect county residents (Womack, Santa Maria Times, 5/31). According to the Times, hundreds of residents in Santa Barbara County -- including more than 100 AIDS Drug Assistance Program (ADAP) clients -- would potentially be affected by the funding cuts (Santa Maria Times, 5/31). The proposal also would result in $1.8 million in cuts to programs for low-income residents living with HIV in Riverside County, the Desert Sun reports (Brambila, Desert Sun, 5/29). The plan, issued by Schwarzenegger last week, includes $55.5 million in cuts to California"s ADAP and other state Office of AIDS programs (Kaiser Daily HIV/AIDS Report, 5/27).
generic viagra
New Mexico Department Of Health Prepares For Influenza Mass Vaccination Clinics Department Continues To Monitor H1N1 Cases
The New Mexico Department of Health is planning for influenza mass vaccination clinics that will take place this fall to protect people against the novel H1N1 strain of influenza (earlier referred to as swine flu) and against seasonal influenza. The Department of Health is also ensuring that the State and its local partners are prepared to deal with the possibility of an increase in severity of H1N1 influenza cases, including a potential pandemic in New Mexico.
News of the day
What Is Anal Cancer? What Causes Anal Cancer?
Anal cancer occurs in the anus, the end of the gastrointestinal tract. Anal cancer is very different from colorectal cancer, which is much more common. Anal cancer"s causes, risk factors, clinical progression, staging and treatment are all very different from colorectal cancer. Anal cancer is a lump which is created by the abnormal and uncontrolled growth of cells in the anus.
Mental Health

BIO Commends Senate Committee On Small Business And Entrepreneurship's SBIR Reauthorization

Under legislation reported by the Senate Committee on Small Business and Entrepreneurship, small companies that receive the majority of their financing from venture capital will once again be considered eligible to compete for Small Business Innovation Research (SBIR) grants. The change will allow more small biotechnology start-ups to compete for these funds and continue critical research and development of medical advancements and breakthroughs. Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood made the following statement today: "For six years, more than half of all small private U.S. biotech companies have not been allowed to compete for SBIR grants due to a bureaucratic ruling. Especially in these troubling economic times, these federal grants could provide considerable support for small companies and the patients awaiting development of new therapies. "I commend the Senate Committee on Small Business and Entrepreneurship, Chairwoman Mary Landrieu, and Ranking Member Olympia Snowe on their hard work to move this process forward. This legislation provides the opportunity for biotech companies to compete on the promise of their science rather than how they are financed. Over 90 percent of the biotech industry is comprised of small businesses engaged in high risk, high reward research and development that benefits us all. "I urge Congress and the Administration to reauthorize the SBIR program as soon as possible in a way that provides a level playing field for all small companies, regardless of their capital structure. I look forward to working with Members of the House and Senate to modernize the SBIR program to reflect the business realities facing small companies in capital-intensive industries, such as biotechnology. And to do so in a way that does not artificially limit the participation of some of our nation"s most innovative and promising small businesses." As a result of the Small Business Administration (SBA)"s reinterpretation of the program"s eligibility requirements in 2003, the applicant pool at the National Institutes of Health (NIH) for SBIR grants has been shrinking. For example, when they became ineligible for SBIR grants, several small biotech firms stopped their work aimed at developing new treatments for cancer and cystic fibrosis. Two years later, NIH Director Elias A. Zerhouni, M.D. told the SBA that limits on SBIR eligibility, "unduly restrict the ability of the NIH to fund high quality, small companies." He expressed concern that the eligibility requirement "undermines NIH"s ability to award SBIR funds to those applicants whom we believe are most likely to improve human health." Patient advocacy groups also have expressed concern about the eligibility restrictions. Sixty patient groups sent a letter to leaders of the 110th Congress in support of reinstating the eligibility of small biotech firms to compete for SBIR grants. In the letter, they asked Congress to "help innovative research move forward in order to foster breakthrough cures. See BIO"s web site and SBIR blog at http://www.hopesandcures.org. BIO


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009